.
Certara
Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include nearly 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries. | Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries.
BrevisRefero
BrevisRefero, in partnership with the educational platform BrickMMO, is pleased to be showcasing an ‘Interactive Biologics CDMO Facility Constructed Exclusively from LEGO(R) Bricks’ at it’s booth (1313) at BIO2024. Join us at our booth for an immersive and educational look at the biologics manufacturing like never before! BrevisRefero is a collection of biologics professionals who share a common goal – to improve and support the management of biologics programs from concept to development, GMP manufacturing and into clinical trials for the benefit of patient and sponsor alike. Pulling from more than 100 years of collective technical biotech consulting experience, we work closely with our clients to develop realistic technical and strategic solutions to support the execution and delivery of biologics programs. BrevisRefero also hosts an RFP outsource management platform called RFP>Navigator(R) that simplifies and accelerates Sponsor’s selection of their CDMO partners. | BrevisRefero Corporation is a team of biopharma professionals with a collective 100 years of biotechnology experience who assist Innovator companies to develop and manufacture their large-molecule biologics for clinical trials and commercial markets. The company assists Innovators by partnering with them at the target molecule post discovery stage and walking with them through their product development journey. Ground-level assistive support is provided in all technical aspects of drug development – from analytical methods and process development, through to scale-up and GMP manufacturing, and every aspect in between supporting their CMC program. Utilizing the deep-seated technical experience of BrevisRefero’s full-time consultants, we have developed innovative world-class online technology tools. Our award-winning commercial product RFP>Navigator®as well as our newly developed BioBudget Champion(TM) tool help propel the biopharma industry forward. Whether it is through our technical knowledge, or its application, BrevisRefero is driven to enable Innovators to succeed in their product development journey.
BioHub Taiwan/National Biotechnology Research Park (NBRP)
The major objectives of the BioHub Taiwan (Innovation Incubation Division) are to foster growth among innovative pharmaceutical businesses via networking and joint-venture opportunities, and to provide access to invaluable R&D and marketing resources. This broad mandate is encapsulated in the image of ‘BioHub Taiwan’, which we seek to promote globally. In addition to startups and small businesses, we welcome the installation of mature firms. We adhere to the ideal that vibrant interaction amid a diverse composition will enable the productive exchange of insights and experiences, and we look forward to fruitful outcomes from seedlings that were nurtured in this environment. We also provide space and cooperation schemes for the establishment or extension of internationally leading accelerators, which can maximize the impact of funding from our country’s investors and venture capital funds.
Benilight
Illuminating the Future of Brain Health: Benilight at BioUSA 2026 The Vision: Beyond Light, Toward Neural Recovery In a world grappling with a growing mental health crisis, Benilight is redefining the boundaries of non-invasive therapy. We don’t just provide devices; we provide a Neural Recovery Ecosystem. At BioUSA 2026, we are proud to unveil the next evolution of our flagship technology: the iLED Pro, now integrated with an AI-powered Medical Doctor App, specifically targeting Post-Traumatic Stress Disorder (PTSD). Core Innovation: The iLED Pro & AI Synergy The iLED Pro is an FDA-listed, professional-grade photobiomodulation (PBM) device. While it has already set industry standards for pain management and tissue recovery, our focus has shifted toward the final frontier: The Brain. Triple-Wavelength Precision: Utilizing a combination of 660nm (Red), 850nm (NIR), and 940nm (NIR), the iLED Pro penetrates deep into cortical tissues to stimulate mitochondrial function and ATP production. Ethical Engineering: Our flexible LED pads are built for the rigors of clinical and home use, tested to withstand over 300,000 bends without losing intensity or integrity. The AI Doctor Integration: Our new AI-driven application acts as a digital clinician. It monitors patient progress, optimizes light dosages based on neurological biofeedback, and provides real-time data to healthcare providers, making the iLED Pro a truly “smart” medical asset. The Indication: A New Hope for PTSD Post-Traumatic Stress Disorder remains one of the most difficult conditions to treat without heavy reliance on pharmaceuticals. Benilight is currently pursuing clinical evidence and regulatory pathways for a PTSD indication, leveraging PBM’s ability to: – Reduce Neuro-inflammation: Calming the physiological “storm” associated with trauma. – Enhance Connectivity: Improving functional connectivity in brain regions impacted by TBI and PTSD. – Optimize Sleep & Circadian Rhythms: Directly addressing the insomnia and night terrors that plague PTSD survivors. Strategic Opportunities for Partners We are at BioUSA to meet the visionaries who will help us scale this life-changing technology globally. Our Value Propositions : – Participation in a high-growth Digital Health firm bridging the gap between MedTech hardware and AI software. – Exclusive access to a versatile, FDA-listed device with a massive untapped market in mental health and sports medicine. – Collaborative opportunities to integrate our LED technology into broader telehealth platforms or specialized clinical chains. Why Visit the Benilight Booth? – Live Demos: Experience the soothing, deep-penetration technology of the iLED Pro firsthand. – The AI Interface: See how our AI App transforms a light therapy device into a sophisticated diagnostic and treatment tool. – Clinical Insights: Speak with our leadership team, including CEO Yosik Song and CTO Dr. Sungkyoo Lim, who brings over 30 years of light-science expertise to the table. Meet Us in San Diego – Event: Bio International Convention (BioUSA) 2026 – Location: San Diego Convention Center – Dates: June 22 – 25, 2026 – Focus: AI-Powered Photobiomodulation for PTSD & Brain Health | Benilight has developed LED medical devices and healthcare products utilizing red LEDs and near-infrared (NIR) LEDs. Our company has conducted extensive research on the effects of LED light on the skin. These devices have been listed as Class II medical devices by the US FDA for pain relief and the enhancement of blood circulation.
Barrington James
Barrington James are an industry leading, global recruitment business that exclusively serves the Pharmaceutical, Biotechnology and Medical Device sectors. With offices all over the world and hundreds of specialists dedicated to sourcing exceptional talent, we have the capacity and capabilities to deliver world-class recruitment solutions to Life Science companies of all sizes.
Auckland UniServices
UniServices is the University of Auckland’s research commercialisation and growth team. We sit at the intersection of research, innovation, and industry, with a mission to grow and commercialise the University’s vast footprint of research expertise.
Apxora
APXORA is an agentic AI SaaS platform supporting pharma, biotech, and medtech organizations by connecting financial and commercial decisions with clinical development and R&D through deployable, enterprise‑ready AI workflows. APXORA offers four core solutions: Asset Lifecycle Manager, Portfolio Manager, Clinical Navigator and Research Nexus. They can be deployed independently or as a connected suite, helping teams break down silos, meet security requirements, and adapt seamlessly to existing infrastructure. Together, these solutions create a built-in workflow that not only mirrors but optimizes decision-making. The result is a continuously connected closed loop system spanning early research through portfolio strategy. The platform can be extended with new tools or integrated with legacy systems, forming a living digital twin of the enterprise that strengthens connectivity, accelerates decisions, and improves efficiency at scale. Asset Lifecycle Manager The platform is a dynamic platform built to manage the full lifecycle of strategic assets. From inception to retirement. It enables users to model, monitor, and optimize the performance of each asset across its entire lifecycle. With advanced simulation tools and powered by agentic AI, users can evaluate how market dynamics, pricing strategies, competitive changes, and operational variables impact asset viability over time. Portfolio Manager The platform represents the culmination of a fully integrated decision support ecosystem, connecting every stage of enterprise value creation from early research signals to long term portfolio performance. Built for complex, innovation driven organizations, the Enterprise Suite fosters seamless collaboration across R&D, asset lifecycle management, and strategic planning. Clinical Navigator Clinical Navigator helps clinical teams design, simulate, and optimize trials using patient-level digital twins and predictive models. Built on generative AI and custom LLMs, it enables faster, smarter trial design and identifies regulatory analogs from FDA and EMA landscapes to guide trial planning. Research Nexus Research Nexus enables teams to generate hypotheses, identify novel targets, and explore drug repurposing opportunities. It provides a custom-built knowledge graph as the foundation for agent orchestration and LLM capabilities, unifying scientific and clinical data for rapid exploration and decision-making.